{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T22:53:59Z","timestamp":1762642439377,"version":"build-2065373602"},"reference-count":30,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["brachyjournal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brachytherapy"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.brachy.2020.12.003","type":"journal-article","created":{"date-parts":[[2021,1,18]],"date-time":"2021-01-18T22:29:14Z","timestamp":1611008954000},"page":"576-583","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["HDR brachytherapy boost using MR-only workflow for intermediate- and high-risk prostate cancer: 8-year results of a pilot study"],"prefix":"10.1016","volume":"20","author":[{"given":"Ferenc","family":"Lakosi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gergely","family":"Antal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janos","family":"Pall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Farkas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tibor","family":"Jenei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denes","family":"Nagy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jozsef","family":"Liptak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Istvan","family":"Sipocz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akos","family":"Pytel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8361-6385","authenticated-orcid":false,"given":"Melinda","family":"Csima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6805-8802","authenticated-orcid":false,"given":"Akos","family":"Gulyban","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabor","family":"Toller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.brachy.2020.12.003_bib1","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.urolonc.2016.06.002","article-title":"What is the best way to radiate the prostate in 2016?","volume":"35","author":"Moon","year":"2017","journal-title":"Urol Oncol"},{"key":"10.1016\/j.brachy.2020.12.003_bib2","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.radonc.2015.02.023","article-title":"High dose-rate brachytherapy boost for intermediate risk prostate cancer: Long-term outcomes of two different treatment schedules and early biochemical predictors of success","volume":"115","author":"Helou","year":"2015","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2020.12.003_bib3","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s00066-019-01553-3","article-title":"Role of combined radiation and androgen deprivation therapy in intermediate-risk prostate cancer: Statement from the DEGRO working group on prostate cancer","volume":"196","author":"Beck","year":"2020","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.brachy.2020.12.003_bib4","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.semradonc.2019.08.003","article-title":"HDR prostate brachytherapy","volume":"30","author":"Crook","year":"2020","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.brachy.2020.12.003_bib5","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/bju.13659","article-title":"Long-term outcomes of high-dose-rate brachytherapy for intermediate- and high-risk prostate cancer with a median follow-up of 10 years","volume":"120","author":"Yaxley","year":"2017","journal-title":"BJU Int"},{"key":"10.1016\/j.brachy.2020.12.003_bib6","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.brachy.2011.01.003","article-title":"Moderate dose escalation with single-fraction high-dose-rate brachytherapy boost for clinically localized intermediate- and high-risk prostate cancer: 5-year outcome of the first 100 consecutively treated patients","volume":"10","author":"\u00c1goston","year":"2011","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2020.12.003_bib7","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.radonc.2020.09.047","article-title":"Randomised trial of external-beam radiotherapy alone or with high-dose-rate brachytherapy for prostate cancer: Mature 12-year results","volume":"154","author":"Hoskin","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2020.12.003_bib8","doi-asserted-by":"crossref","first-page":"658","DOI":"10.3109\/0284186X.2012.744875","article-title":"Improved tumour control probability with MRI-based prostate brachytherapy treatment planning","volume":"52","author":"Dinkla","year":"2013","journal-title":"Acta Oncol"},{"key":"10.1016\/j.brachy.2020.12.003_bib9","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1080\/0284186X.2018.1445284","article-title":"MRI-only based radiation therapy of prostate cancer: Workflow and early clinical experience","volume":"57","author":"Tenhunen","year":"2018","journal-title":"Acta Oncol"},{"key":"10.1016\/j.brachy.2020.12.003_bib10","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.brachy.2016.11.012","article-title":"Clinical use of magnetic resonance imaging across the prostate brachytherapy workflow","volume":"16","author":"Blanchard","year":"2017","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2020.12.003_bib11","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.brachy.2015.12.004","article-title":"Lessons learned using an MRI-only workflow during high-dose-rate brachytherapy for prostate cancer","volume":"15","author":"Murgic","year":"2016","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2020.12.003_bib12","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.brachy.2016.03.011","article-title":"Learning curve of MRI-based planning for high-dose-rate brachytherapy for prostate cancer","volume":"15","author":"Buus","year":"2016","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2020.12.003_bib13","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.brachy.2019.02.003","article-title":"Dose to the bladder neck in MRI-guided high-dose-rate prostate brachytherapy: Impact on acute urinary toxicity and health-related quality of life","volume":"18","author":"Sanmamed","year":"2019","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2020.12.003_bib14","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.brachy.2016.09.004","article-title":"Image-guided high-dose-rate brachytherapy boost to the dominant intraprostatic lesion using multiparametric magnetic resonance imaging including spectroscopy: Results of a prospective study","volume":"15","author":"Vigneault","year":"2016","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2020.12.003_bib15","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.brachy.2017.03.004","article-title":"Magnetic resonance imaging basics for the prostate brachytherapist","volume":"16","author":"Wang","year":"2017","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2020.12.003_bib16","doi-asserted-by":"crossref","first-page":"20190089","DOI":"10.1259\/bjr.20190089","article-title":"Multiparametric MRI-guided dose boost to dominant intraprostatic lesions in CT-based High-dose-rate prostate brachytherapy","volume":"92","author":"Wang","year":"2019","journal-title":"Br J Radiol"},{"key":"10.1016\/j.brachy.2020.12.003_bib17","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1007\/s00330-019-06505-0","article-title":"MRI targeted single fraction HDR Brachytherapy for localized Prostate Carcinoma: A feasibility study of focal radiation therapy (ProFocAL)","volume":"30","author":"Fischbach","year":"2020","journal-title":"Eur Radiol"},{"key":"10.1016\/j.brachy.2020.12.003_bib18","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1080\/0284186X.2017.1349333","article-title":"Clinical outcome in prostate cancer treated with magnetic resonance imaging-guided high-dose-rate brachytherapy combined with external beam radiotherapy","volume":"56","author":"Lakosi","year":"2017","journal-title":"Acta Oncol"},{"key":"10.1016\/j.brachy.2020.12.003_bib19","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s12253-010-9319-x","article-title":"Open MR-guided high-dose-rate (HDR) prostate brachytherapy: Feasibility and initial experiences open MR-guided high-dose-rate (HDR) prostate brachytherapy","volume":"17","author":"Lakosi","year":"2011","journal-title":"Pathol Oncol Res"},{"key":"10.1016\/j.brachy.2020.12.003_bib20","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/S0360-3016(00)00487-9","article-title":"Chronic effects of therapeutic irradiation for localized prostatic carcinoma on anorectal function","volume":"47","author":"Yeoh","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2020.12.003_bib21","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s40471-016-0089-1","article-title":"Methodologic issues when estimating risks in Pharmacoepidemiology","volume":"3","author":"Edwards","year":"2016","journal-title":"Curr Epidemiol Rep"},{"key":"10.1016\/j.brachy.2020.12.003_bib22","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.ijrobp.2019.11.415","article-title":"Radiation dose escalation or longer androgen suppression to prevent distant progression in men with locally advanced prostate cancer: 10-year data from the TROG 03.04 RADAR trial","volume":"106","author":"Joseph","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2020.12.003_bib23","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1016\/j.ijrobp.2004.01.016","article-title":"MRI-guided HDR prostate brachytherapy in standard 1.5 T scanner","volume":"59","author":"M\u00e9nard","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2020.12.003_bib24","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.radonc.2016.02.004","article-title":"Dose escalation to dominant intraprostatic lesions with MRI-transrectal ultrasound fusion high-dose-rate prostate brachytherapy. Prospective phase II trial","volume":"119","author":"Gomez-Iturriaga","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2020.12.003_bib25","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1080\/0284186X.2017.1400690","article-title":"Pudendal nerve injury impairs anorectal function and health related quality of life measures \u22652 years after 3D conformal radiotherapy for prostate cancer","volume":"57","author":"Yeoh","year":"2018","journal-title":"Acta Oncol"},{"key":"10.1016\/j.brachy.2020.12.003_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13014-019-1262-8","article-title":"A systematic review of dose-volume predictors and constraints for late bowel toxicity following pelvic radiotherapy","volume":"14","author":"Jadon","year":"2019","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.brachy.2020.12.003_bib27","article-title":"Triggered imaging with auto beam hold and pre-\/posttreatment CBCT during prostate SABR: Analysis of time efficiency, target coverage, and normal volume changes","author":"Kisivan","year":"2020","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.brachy.2020.12.003_bib28","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.ijrobp.2017.10.020","article-title":"Magnetic resonance imaging-guided adaptive radiation therapy: A \u201cgame changer\u201d for prostate treatment?","volume":"100","author":"Pathmanathan","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2020.12.003_bib29","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.radonc.2014.10.007","article-title":"Dosimetric analysis of urethral strictures following HDR 192Ir brachytherapy as monotherapy for intermediate- and high-risk prostate cancer","volume":"113","author":"D\u00edez","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2020.12.003_bib30","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.brachy.2012.03.004","article-title":"Urethral strictures following high-dose-rate brachytherapy for prostate cancer: Analysis of risk factors","volume":"12","author":"Hindson","year":"2013","journal-title":"Brachytherapy"}],"container-title":["Brachytherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472120302932?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472120302932?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T02:16:43Z","timestamp":1761531403000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538472120302932"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S1538472120302932"],"URL":"https:\/\/doi.org\/10.1016\/j.brachy.2020.12.003","relation":{},"ISSN":["1538-4721"],"issn-type":[{"type":"print","value":"1538-4721"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HDR brachytherapy boost using MR-only workflow for intermediate- and high-risk prostate cancer: 8-year results of a pilot study","name":"articletitle","label":"Article Title"},{"value":"Brachytherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brachy.2020.12.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 American Brachytherapy Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}